Evidence map›Paper›PMID 38441612›Full record

ArticleJournal of neurology2024

The cognitive relevance of non-lesional damage to cortical networks in people with multiple sclerosis.

Eva A Krijnen, Tommy A A Broeders, Samantha Noteboom, Maureen van Dam, Albulena Bajrami, Piet M Bouman, Frederik Barkhof, Bernard M J Uitdehaag, Eric C Klawiter, Ismail Koubiyr and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 4 countries.

Eva A KrijnenMS Center Amsterdam, Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, 1007 MB, Amsterdam, The Netherlands. e.a.krijnen@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-3628-4127
Tommy A A BroedersMS Center Amsterdam, Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, 1007 MB, Amsterdam, The Netherlands.
Samantha NoteboomMS Center Amsterdam, Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, 1007 MB, Amsterdam, The Netherlands.
Maureen van DamMS Center Amsterdam, Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, 1007 MB, Amsterdam, The Netherlands.
Albulena BajramiMS Center Amsterdam, Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, 1007 MB, Amsterdam, The Netherlands.
Piet M BoumanMS Center Amsterdam, Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, 1007 MB, Amsterdam, The Netherlands.
Frederik BarkhofMS Center Amsterdam, Radiology and Nuclear Medicine, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC Location VUmc, 1081 BT, Amsterdam, The Netherlands.
Bernard M J UitdehaagMS Center Amsterdam, Neurology, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, 1081 HV, Amsterdam, The Netherlands.
Eric C KlawiterDepartment of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Ismail KoubiyrMS Center Amsterdam, Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, 1007 MB, Amsterdam, The Netherlands.
Menno M SchoonheimMS Center Amsterdam, Anatomy and Neurosciences, Amsterdam Neuroscience, Amsterdam UMC Location VUmc, 1007 MB, Amsterdam, The Netherlands.
Amsterdam Neuroscience · NLHarvard University · USMassachusetts General Hospital · US

Funding

ZonMw 09150172010056
6 · The paper itself

Abstract

backgroundCognitive impairment, a common and debilitating symptom in people with multiple sclerosis (MS), is especially related to cortical damage. However, the impact of regional cortical damage remains poorly understood. Our aim was to evaluate structural (network) integrity in lesional and non-lesional cortex in people with MS, and its relationship with cognitive dysfunction.

methodsIn this cross-sectional study, 176 people with MS and 48 healthy controls underwent MRI, including double inversion recovery and diffusion-weighted scans, and neuropsychological assessment. Cortical integrity was assessed based on fractional anisotropy (FA) and mean diffusivity (MD) within 212 regions split into lesional or non-lesional cortex, and grouped into seven cortical networks. Integrity was compared between people with MS and controls, and across cognitive groups: cognitively-impaired (CI; ≥ two domains at Z ≤ - 2 below controls), mildly CI (≥ two at - 2 < Z ≤ - 1.5), or cognitively-preserved (CP).

resultsCortical lesions were observed in 87.5% of people with MS, mainly in ventral attention network, followed by limbic and default mode networks. Compared to controls, in non-lesional cortex, MD was increased in people with MS, but mean FA did not differ. Within the same individual, MD and FA were increased in lesional compared to non-lesional cortex. CI-MS exhibited higher MD than CP-MS in non-lesional cortex of default mode, frontoparietal and sensorimotor networks, of which the default mode network could best explain cognitive performance.

conclusionDiffusion differences in lesional cortex were more severe than in non-lesional cortex. However, while most people with MS had cortical lesions, diffusion differences in CI-MS were more prominent in non-lesional cortex than lesional cortex, especially within default mode, frontoparietal and sensorimotor networks.

Indexed as

Cerebral CortexCognitive DysfunctionMultiple SclerosisNerve NetAdultCross-Sectional StudiesDiffusion Magnetic Resonance ImagingFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsCognitionCortical lesionsDiffusionMultiple sclerosisNetworks

Identifiers

PMID38441612
PMCPMC11136718
OpenAlexW4392456133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.